Epidemiology of the hepatitis C virus

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 143-146

  Ebeling, Freja ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; DISEASE CARRIER; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MORBIDITY; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 0031824721     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05412.x     Document Type: Conference Paper

References (14)

1. WHO Weekly epidemiological record:Hepatitis C: global prevalence. WHO Weekly Epidemiological Record 1997;72:341-344.
2. Mizokami M, Gojobori T, Lau JYN:Molecular evolutionary virology: its applivation to hepatitis C virus. Gastroenterology 1994;107:1181-1182.
3. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Lin M, Nuchaprayoon C, Ndimbie OK, Yap PL:Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region, J Gen Virol 1995;76:1197-1204.
4. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, Vasychova F, Widell A, Roggendorf M:Hepatitis C genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 1997;53:36-40.
5. Alter HJ:To C or not to C: These are the questions. Blood 1995;85:1681-1695.
6. Bolumar F, Hernandez-Aguado I, Ferrer L, Ruiz I, Avino MJ, Rebagliato M:Prevalence of antibodies to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992. Int J Epidemiol 1996;25:204-209.
7. van der Poel CL, Ebeling F:Hepatitis C virus: Epidemiology, transmission and prevention (in press). In H.W.Reesink (ed); Hepatitis C virus, 2nd edition, Karger 1998.
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, for the retrovirus epidemiology donor study:The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
9. Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, Grillner L, Persson MA:Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607.
10. Esteban JI, Gómez J, Martell M, Gabot B, Quer J, Camps J, González A, Otero T, Moya A, Esteban R, Guardia J:Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-560.
11. Schvarcz R, Nyström B, Oksanen A, Sönnerborg A:Prevention of nosocomial transmission of hepatitis C virus. Lancet 1995;346:190.
12. Porter SR; Lodi G:Hepatitis C virus (HCV) -an occupational risk to dentists? Br Dent J 1996;180:473-474.
13. Bronowicki J-P, Venard V, Botté C, Monhoven N, Gastrin I, Choné L, Hudziak H, Rhin B, Delanoë C, LeFaou A, Bigard M-A, Gaucher P:Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337:237-240.
14. Gerberding JL:Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-451.